Company Monitoring Page for JNJ

job ratings (see below graph) for JNJ

latest headlines for company on cafepharma

J&J and Bayer's Xarelto cuts recurrence of dangerous blood clots in study
Yahoo/Reuters
Sun, 03/19/17 - 11:22 am
Tags:
JNJ, Bayer, Xarelto, blood clots, bloodthinners
J&J’s DePuy Synthes touts economic benefits shown in Attune knee study
Mass Device
Thu, 03/16/17 - 09:47 am
Tags:
JNJ, DePuy Synthes, Attune knee, knee replacement, devices
SXSW panel: IBM, Johnson & Johnson CEOs say tech, medicine collaboration offers huge upside
Bizjournals.com
Mon, 03/13/17 - 04:41 pm
Tags:
JNJ, IBM, SXSW, technology
Merck and Pfizer prep for battle with SGLT2, combo diabetes filings
Fierce Pharma
Mon, 03/13/17 - 10:18 am
Tags:
Merck, Pfizer, SGLT2 inhibitor, diabetes, ertugliflozin, Jardiance, Boehringer Ingelheim, Eli Lilly, JNJ, Invokana, AstraZeneca, Farxiga
13 more women leaders in medtech
Mass Device
Sun, 03/12/17 - 11:06 am
Tags:
devices, Cindy Kent, 3M, Stacey Pugh, Medtronic, Sandi Peterson, JNJ, Kathryn Wengel, Ashley McEvoy, Stephanie Muir, Ethicon, Renee Ryan, Martha Shadan, Rotation Medical, Marie Johnson, AUM Cardiovascular, Sherri Dodd, Lee Jones, Rebiotix, Elizabeth McCombs, Nancy Briefs, MyndBlue
The 3 Most Important Numbers for Johnson & Johnson
Motley Fool
Sun, 03/12/17 - 10:54 am
Tags:
JNJ, devices, Remicade
J&J taps the power of empathy with apps that take wellness beyond its products
Fierce Pharma
Sat, 03/11/17 - 11:50 am
Tags:
JNJ, patients, mobile apps
The Lawsuits Keep Coming for Johnson & Johnson
Bloomberg
Fri, 03/10/17 - 09:56 am
Tags:
JNJ, Xarelto, consumer health, hip implants, pelvic mesh
Johnson & Johnson wins trial in talcum product liability lawsuits
Mass Device
Sat, 03/4/17 - 01:57 pm
Tags:
JNJ, lawsuits, devices
J&J may be late to the psoriasis drug market party, but it’s planning to make a splash with guselkumab
Endpoints
Fri, 03/3/17 - 09:36 am
Tags:
JNJ, psoriasis, guselkumab
4 Reasons Johnson & Johnson Surged 8% in February
Motley Fool
Thu, 03/2/17 - 03:46 pm
Tags:
JNJ, Darzalex, Actelion, Donald Trump
Big Pharma Pushes Back on Drug-Price Complaints
Investopedia
Wed, 03/1/17 - 09:22 pm
Tags:
drug pricing, Big Pharma, JNJ, Merck
The world's biggest drugmaker just pulled back the curtain on drug pricing
Yahoo/Business Insider
Mon, 02/27/17 - 10:29 pm
Tags:
drug pricing, JNJ
Johnson & Johnson closes $4.3B Abbott Medical Optics buy
Mass Device
Mon, 02/27/17 - 09:08 am
Tags:
JNJ, devices, M&A, Abbott Medical Optics, eye health
Johnson & Johnson May Already Have Its Remicade Replacement Well in Hand
Motley Fool
Sat, 02/25/17 - 03:21 pm
Tags:
JNJ, Remicade, Darzalex, Genmab, Multiple Myeloma
These HIV Regimens Are Expected to See Solid Global Demand in 2017
Market Realist
Fri, 02/24/17 - 09:18 am
Tags:
Gilead Sciences, Pfizer, GSK, JNJ, tenofovir
Anyone really shopping for Bristol-Myers?
BioPharma Dive
Thu, 02/23/17 - 09:18 am
Tags:
M&A, Bristol-Myers Squibb, JNJ, Pfizer
Pfizer, Celltrion pushing for interchangeability with Inflectra
BioPharma Dive
Thu, 02/23/17 - 09:11 am
Tags:
Pfizer, Celltrion, Inflectra, JNJ, biosimilars, Remicade
J&J leads pharma in Fortune's most admired companies list
BioPharma Dive
Tue, 02/21/17 - 10:31 pm
Tags:
JNJ
Torax Medical agrees to sell to Johnson & Johnson subsidiary
Bizjournals.com
Tue, 02/21/17 - 11:10 am
Tags:
JNJ, Torax Medical, M&A, devices, Ethicon

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.